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ABSTRACT Homophilic interactions of E-cadherin serve the organization of embryonic and adult
epithelia and counteract cancer invasion. The role of E-cadherin as an invasion-suppressor molecule
has been demonstrated cancer. Regulation of embryonic ingression and cancer invasion via E-cadherin
occurs at transcriptional, translational and post-translation levels.
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Introduction
Cancer development from epithelial cells may proceed along the
following scenario: genetic alterations result in loss of growth
control leading to the formation of a tumor. This tumor is benign,
meaning that the cells stay together. Other genetic a1terations
result in loss of cell-cell adhesion leading to detachment of cells.
Such a tumor is malignant. meaning that it does invade and that it
may metastasize (Mareel et at.. 1990).
During initial cleavage of the mouse egg, the blastomeres move
freely inside the zona pellucida, as is shown by in vivo time lapse
videomicrography (Fink, 1991). At a given time, compaction occurs
by the simultaneous clingingtogether of the blastomeres. They form
an epithelium that builds up the wall of the blastocyst. As described
by Monod's group in Paris, this compaction is accompanied by the
appearance of a Cell Adhesion Molecule (CAM) on the surface ofthe
cells. The term uvomoruHn was coined for the molecule, from uva
(a bunch of grapes) and morula (mulberry). More importantly, anti-
bodies against uvomorulin inhibited the compaction (Hyafil et al.,
1980; Peyrieras et al., 1983). This was a promising step towards
the biochemical explanation of selective cohesion of cells during
embryonic development as demonstrated in the seminal paper by
Townes and Haltfreter (1955).
The major difference between embryogenesis and cancer de-
velopment is that the scenario of the former follows a strict and
predictable time schedule, whereas the sequences in the scenario
of the latter are unpredictable (Mareel et at., 1991a, 1992: Mareel
et al., in press). Among human tumors, colon cancer is about the
only one that is suitable for a sequential analysis of the molecu!ar
genetics underlying the transition between normal and benign, and
between benign and malignant conditions (Fearon and Vogelstein,
1990).
Recently, the compaction-related cel1-cell adhesion molecule
uvomorulin has been implicated also in cancerdevelopment(Behrens
et al., 1992; Van Roy and Mareel. 1992). The present review
discusses the role of uvomorulin, called here E-cadherin, in embry-
onic ingression and cancer invasion with emphasis on the transcrip-
tional and post-transcriptional modulation of its expression.
E-cadherin and cell-cell adhesion
The adhesion molecules that have been most intensively studied
with respect to epithelial cell-cell adhesion are encoded by genes of
the cadherin superfamily (Edelman and Crossin, 1991; Takeichi,
1991; Kemler, 1992). One ofthese cell-cell adhesion molecules, E-
cadherin (identical to or homologous with uvomorulin, L-CAM,Arc-
1 and cell CAM 120/180) is expressed in most embryonic and adult
epithelia. Moreover, it might serve as an organizer(mastermolecule)
of adherens junctions leading in a cascade of events to epithelial
organogenesis (Gumbiner et al., 1988: Magee and Buxton, 1991:
Roui]]er et a/.. 1991; Shore and Nelson, 1991).
The locus for human E-cadherin has been mapped to a subregion
within band 16q22.1 (Natt et al., 1989). E-cadherin is synthesized
from a 4.5-kb mRNA as a 135-kDa precursor polypeptide which is
rapidly (2 h) and efficiently (100%) processed to the mature 120-kD
form before delivery to the cell surface (Shore and Nelson, 1991).
The turnover of E-cadherin at the cell surface has a half life of about
5 h. The mature E-cadherin is an integral membrane glycoprotein
with a single membrane spanning domain and an extracellular
domain that is implicated in homophilic binding by an as yet
unidentified mechanism (Fig. 1). The cytoplasmic domain is
noncovalently linked to catenins. Catenins are believed to be parts
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Fig. 1. The molecular domain structure of the 120-kDa functional
mature mouse E-cadherin (very high homology in functional domains
with human E-cadherin) contains 728 amino acid residues. N, amino-
terminus; C. carboxy-terminus; P, phosphorylation sites on 5er and Thr
residues; Ca2+,putative calcium-binding domains; flags are potentia!
glvcosylation sites; PM, plasma membrane. The amino-terminal fragments
(residues 1 to 113and, in particular, the underlined amino acid residues} are
essential for intercellular binding and determine binding specificity. The
DECMA-1 antibody epitope is located centrally near a cystein-rich domain.
A highly conserved C-terminal domain essential for stable cell-celf adhe-
sion is underscored. n. p. r and other indicate catenins. Modified after
McCrea and Gumbiner (1991), Ozawa et al. (1990a,b) and Takeichi (1991).
The lower part of the figure summarizes possible causes of dysfunction of
E-cadherin.
of a multicomponent submembranous network which connects E-
cadherin to other integral membrane proteins and tothe cytoskeleton
(Nelson et al., 1990; Ozawa and Kemler, 1992). The structure and
subcellular localization of E-cadherin is compatible with a role not
only in cell-cell adhesion but also in signalling.
To explore the function of E-cadherin various assays have been
used. In vitro, the following phenotypes, all expressed in presence
of Ca2+, point to functional E-cadherin: fast (30 min) cellular
aggregation (Takeichi, 1977; Kadmon et al., 1990); compaction,
i.e. formation of compact aggregates as compared to loose clusters
after overnight incubation (Matsuyoshi et at., 1992); epithelial or-
ganization on solid tissue culture substrate (Shore and Nelson,
1991); epithelial organization around fragments of embryonic chick
heart in organ culture (Behrens et al., 1989; VJeminckx et al., 1991;
Mareel et a/.. 1992); clustering on top of collagen gels (Vakaet et
al., 1991); low dispersion index, i.e. tight colony formation
(Matsuyoshi et al., 1992) and formation of glandular structures
(pignatelli et al., 1992) inside collagen gels.
In vivo, formation of epithelial structures is a good indication for
expression of functional E-cadherin (Mareel et at., 1991b, 1992;
Vleminckx et at., 1991).
Phenotypes expressed in the different assays may reveal differ-
entaspects of E-cadherin function. For instance, 3Y1 rat fibroblastic
cells formed aggregates in a short term assay as well as compaction
after overnight incubation, whereas their src -transformed deriva-
tives SR3Y1 scored positive in the fast aggregation assay but not
in the compaction assay(Matsuyoshi et at., 1992). MCF-7/6 human
breast cancer cells produced epithelial sheets on solid substrate
but failed to aggregate in the short term assay, in contrast to their
counterpart MCF-7/AZ cells which scored positive in both assays
(our unpublished results). It is our opinion that each assay has to
be considered as a different micro-ecosystem, the elements of
which mayor may not influence the expression of the E-cadherin-
dependent phenotypes (Mareel et a/., 1992).
The E-cadherin-dependence of the expression of the phenotypes
in the above-mentioned assays in vitro has been demonstrated
through inhibition with E-cadherin-specific antibodies (Behrens et
al., 1989; Vleminckx et al., 1991; Pignatelli et al., 1992). It should
be recalled here that it was antibody-mediated prevention of
compaction of preimplantation mouse embryos that led to the first
detection of E-cadherin (Hyafil et a/., 1980).
In the two step scenario of cancer development, we have
considered growth and invasion as unrelated (Mareel et at.. 1990).
Growth would depend upon inactivation oftumor suppressor genes,
and invasion upon loss of cell-cell adhesion molecules among other
invasion-promoting events. There are, however, indications that the
situation is less simple in as much as cell-cell adhesion molecules
may be also implicated in growth, although direct evidence for this
implication is missing. Some tumor suppressor gene products were
found to possess similarity with cell-cell adhesion molecules. The
Drosophila fat gene, one of the seven known Drosophila tumor
suppressor genes, belongs to the cadherin gene superfamily; it
encodes a very large transmembrane protein of more than 5, 000
amino acids with 34 tandem cadherin domains, 4 EGF-like repeats,
a transmembrane domain and a cad herin-unrelated novel cytoplas-
mic domain (Mahoney et al., 1991). Recessive mutations in the fat
locus cause loss of single layered epithelial structure (cell-cell
adhesion) and tumor formation (growth) in the larval imaginal discs.
The human DCe (deleted in colon cancer) gene has been implicated
in growth control of the colon mucosa (Fearon and Vogel stein,
1990; Tanaka et al., 1991). A recent report does, however, impli-
cate the inactivation of the Dee gene in the progression from
noninvasive to invasive colon carcinoma on the basis of loss of
heterozygosity on chromosome 18q including the DCe locus (Kikuchi-
Yanoshita, 1992). Neither for the fat gene nor for the DCC gene
products has it been demonstrated that they actually function as
cell-cell adhesion molecules. Since the cytoplasmic domain of the
fat gene product is different from that of the cadherins, and since
an intact cadherin cytoplasmic domain is needed for cell-cell
adhesion, one may presume different mechanisms for both types
of molecules, at least with regard to adhesion. A relationship
between adhesion and growth was also suggested by the experiments
of Navarro et at. (1991) and of Vleminckx et at. (1991); tumors
produced by injection of E-cadherin-positive cells did grow more
slowly than tumors from E-cadherin-negative cells.
Whether alteration of growth results from direct signalling through
cadherin or is an indirect consequence of altered tissue organization
remains to be examined.
Patterns of E-cadherin expression
During avian gastrulation, cells of the upper layer lose their
coherence and ingress through the primitive streak. Studying the
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Fig. 2. Staining of MOCK canine kidney cells in culture on glass with OAPI (panels A. C. E and G) and with antibody OECMA-' followed by FITC-
conjugated sheep anti-mouse IgG (panels S, 0, F and H). The figure shows consecutive stages of mitosis: prophase (A and B); metaphase (C and
OJ; anaphase (E and F); telophase (G and HI. The E-cadherin immunosignal of the mitotic cells is in focus slightly above the Immunosignal of the
interphase cells_ Scale bar= 10 11m.
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chicken blastoderm at stage 9 (Vakaet. 1970), Edelman er al.
(1983) showed immunohistochemically that L-CAM was present
between the cells of the upper layer in the groove of the primitive
streak. Fig. ic in the latter paper clearly shows that L-CAMis present
all around the cells in mitosis. This is what we found also for MDCK
cells in culture on glass (Rg. 2). L-CAM was still present on recently
ingressed interphase middle layer cells. Later, the loss of cell-cell
adhesion leading to detachment of the middle layer cells was
accompanied by loss of the expression of L-CAM. During
organogenesis. in some tissues cell<ell adhesion may be reinstated.
One example is the formation of nephric tubules outot mesenchyme.
Vestweber et al. (1985) looked for the presence of uvomorulin in
metanephrogenic tissue of rabbits during experimental induction of
tubules. They found that 12 h after induction. uvomorulin was
present in the formed tubules but not before. The authors did not
succeed in preventing formation of tubules by anti-uvomorulin
antibodies, although they demonstrated that the antibodies had
penetrated into the tissue and were bound to the uvomorulin. They
concluded that other cell surface molecules may be sufficient for
this morphogenetic process.
Since the paper on the expression of E-<:adherin in a variety of
human tumors and normal tissues published by Eidelman et al.
(1989). a number of reports have appeared including cancers
originating from the following tissues: skin (Czech er al..1990): breast
(Shiozaki et a/., 1991); upper respiratory and alimentary tract, head
and neck, (Schipper er al., 1991): esophagus (Shiozaki ef al..
1991); gastric mucosa (Shimoyama and Hirohashi, 1991; Shiozaki
er al.. 1991): lung (Shimoyama ef al..1989): arachnoid villi (Tohma
er al.. 1992): colon (Van Aken er al.. 1991; Dorudi er al.. 1992):
prostate (Bussemakers. 1992). In these tissues. immunostaining
with an E-cadherin-specific antibody shows homogeneous positivity
in the epithelia of origin and in benign tumors (e.g. pOlyps) and
heterogeneity in malignant tumors with quantitative and qualitative
changes of the immunosignal (Fig. 3). Alterations of E-cadherin are
most obvious in the less well differentiated tumors which are also
the more aggressive ones (Mareel et a/.. 1991a: Gabbert et at..
1992). Taken together these data show alterations in E-cadherin
expression in malignant. Le. invasive, cancers in agreement with
the idea that E-<:adherin is an invasion-suppressor molecule (Behrens
ef al.. 1992: Van Roy and Mareel, 1992). We should, however,
consider that immunostaining is instructive about the presence of
the antigen but does not explore the function of the molecule.
Furthermore, these static observations do not tell us wether or not
expression of E-cadherin is the key event in epithelial organization
and whether or not down-regulation of E-<:adherin is responsible for
ingression and invasion.
Experimental evidence in favor of a master role for E-
cadherin
For cancer development, 4 types of experimental manipulations
in vitro have provided arguments in favor of an invasion-suppressor
role of E-cadherin in various epithelium-derived cell types (Behrens
er al.. 1989, 1992; Chen and Obrink, 1991: Frixen ef al.. 1991:
Vleminckx ef al.. 1991; Mareel er al.. 1992b: Van Roy and Mareel,
1992). First. a negative correlation was found between the expression
of E-cadherin and invasion in vitro for several families of animal cell
lines and for a variety of human cancer cell lines. Second, in E-
cad herin-negative cancer cell types, invasion could be abrogated by
transfection and expression of exogenous E-cadherin cDNA. Third,
reduction of E-cadherin mRNA levels after transfection with a
plasmid expressing E-cadherin-specific antisense RNA induced the
invasive phenotype in E-cadherin-positive and invasion-negative
cells. Fourth, in cells expressing the endogenous orthe exogenous
E-cadherin at high and homogeneous levels, invasion could be
induced by addition of some antibodies inactivating functional E-
cadherin. Note that not all antibodies are functionally inactivating
despite their specific binding and that the antigen cannot always be
reached by the antibody. In cell lines derived from a normal murine
mammary gland, E-<:adherin-negative cells only became invasive
after introduction of a powerful oncogene like ras (Vleminckx et al.,
1991), The invasive behavior of these cells was suppressed by
transfection with E-cadherin cDNA, whereas their levels of ras
expression remained the same, indicating that E-<:adherin may
counterbalance the invasion promoter activity of oncogenes. How
such oncogenes induce the expression of the invasive phenotype
and at what level this is counterbalanced by E-cadherin is an open
question (Mareel and Van Roy, 1986: Van Roy and Mareel, 1992).
Levels of E-cadherin regulation
Cadherins are plasma membrane receptors, sensitive to regu-
lation at various levels.
In tumors no mutations have been found for cadherins, so far,
although mutant E-cadherins have been expressed in cultured cells
(Ozawa ef al.. 1990). Loss of heterozygosity (LOH) at specific
chromosomal locations is accepted as an indication of a tumor
suppressor gene at these locations. In prostate cancer, LOH at
chromosome 16q was a frequent (30%) event (Carter er al..1990).
LOH at 16q was found also in 3 out of 25 tumors from the
neurectoderm (Thomas and Raffel, 1991) and in breast cancer,
allele loss on 16q correlated positively with lymph node metastases
(Sato et al., 1990), In hepatocellular carcinomas, a tumor suppres-
sor gene has been localized on chromosome 16q22,1 to 16q23.2,
i.e. the region where the E-cadherin gene is located (Tsuda et al.,
1990). The late loss of this allele during hepatocarcinogenesis is
consistent with an invasion suppressor role of E-cadherin in these
tumors, DNA sequences sensitive to tissue-specific regulatory
elements have been identified in the E-<:adherin promoter (Behrens
et al., 1992); in a CAT (Chloramphenicol Acetyl Transferase) reporter
assay, these sequences were found to be highly active in differen-
tiated breast carcinoma cells but not in undifferentiated carcinoma
cells. One major problem with genomic alterations is that they are
seldom unique but mostly associated with multiple others on the
--------Figs. 3 to 6. E-cadherin immunohistochemistry of different human colon tumors, namely adenoma 131. well-differentiated 141;moderately
differentiated (5) and poorly differentiated (6) carcinoma. Panels B show details of boxed-in areas of panels A. Frozen sections were treated with
a mouse monoclonal antibody against human E-cadherin (MLCA; Euro-Diagnosrics B. v.. Ape/doorn, The Netherlands) followed by a modified PAP
technique. Scale bars= 50 11m.
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Fig. 7. Schematic representation of a micro-ecosystem of invasionl
ingression: ;.= invasion (or ingression)-promoter gene, encoding mol-
ecules that govern the expression of the invaSive phenotype; r= invasion(or ingression)-suppressor gene. encodmg molecules that govern the
organization of coherenr epithelial structures. Adapted from Mareelet af.
(1991a).
same or on other chromosomes. This makes it difficult to establish
causal relationships between chromosomal changes and tumor
phenotypes. and it has even been proposed that the accumulation
of allelic deletions is more important than the order in which they
occur (Fearon and Vogel stein, 1990). Developmentally regulated
expression of cadherin by trans-acting factors can be analyzed with
the dominant mutants that have been derived from compaction-
competent embryonal carcinoma cell lines but that lack E-{;adherin
expression and that have lost the compaction-competence (Weng
and Littlefield, 1991).
With experimentat tumors, down-regulation of both endogenous
and transfected E-cadherin expression has been demonstrated
after injection of homogeneously E-cadherin-positive cell populations
into host animals (Mareel et aJ., 1991b; Vleminckx et al_.1991: Gao
et al., 1992). In one of these experiments down-regulation was
shown to occur at the transcriptional level (Gao et al.. 1992).
Mesenchymal cells from a fetal mouse are at the origin of the M04
cell line. The latter cells did not express E-cadher;n, probably
because of permanent down-regulation during embryonic develop-
ment. Transfection of M04 cells with E-cadherin cDNA resulted in
the isolation of M04 ce11sthat did express exogenous E-cadherin at
their surface. The molecule seemed to be functional in as much as
the transfectants, in contrast with the parental cells. showed Ca2+.
dependent fast aggregation and did not invade into collagen gel.
When E-cadherin-positive M04 cells were injected into syngeneic
mice, they produced invasive and metastatic tumors in which no E-
cad herin-positive cells could be detected by immunohistochemistry,
By Northern blotting it was shown that the levels of E-cadherin mRNA
were at least 10 times lower in the tumors than in the cells that were
injected. When these tumors were brought into culture, cells started
to re-express E-cadherin readily. These observations indicate down-
regulation of E-cadherin at the transcriptional level under the
influence of host factors. It is puzzling that this down-regulation
occurs despite the fact that the transfected E-cadherin is under the
control of a constitutive 8-actin promoter (Nagafuchi et al., 1987).
Temporary down-regulation of E-cadherin in invasive rat prostate
cancers with re-expression in some parts ofthe metastases formed
occurred also at the transcriptional level as evidenced by Northern
blot analysis (Bussemakers et al.. 1992). However, in human
prostate cancer, no correlation was found between E-cadherin
mRNA levels and the E-cadherin immunosignal (Bussemakers.
1992). Using in situ hybridization, a technique that takes into
account heterogeneity within a single tumor, SChipper et al. (1991)
and Dorudi et aI, (1992) did find a correlation between low E-
cadherin immunosignal and reduced levels of mRNA in human head
and neck tumors and in human colon cancers. respectively.
Post-translational modulation of E..cadherin, with or without
alteration of the immunosignal, is an alternative to transcriptional
regulation and can occur at various levels (see Fig. 1). Since E-
cadherin is a glycoprotein of the comptex type, glycosylation may be
a way of fine tuning, too. Experiments with tunicamycin-treated
MOCK cells have led to the conclusion that core or complex
carbohydrates are not required for processing and transport to the
surface of E<:adherin (Shore and Nelson, 1991). The role of the
carbohydrate residues in the adhesion or the signalling function of
E-cadherin remains to be explored.
Ca2+ is needed for the stabilization of cadherins and for their
correct assembly into adherens junction complexes. Since
extracellular calcium levels are known to vary within tissues, this
provides another possible mechanism of regulation of cadherin,
e.g. during epithelial-mesenchymal transition (Magee and Buxton.
1991).
Catenins are directly associated with the cytoplasmic domains
of E-cadherin as well as of other members of the cadherin family.
Members of the catenin family are: rl-catenin (102 kDa), showing
homology to vinculin (Herrenknecht et at..1991); B-catenin (88 kDa),
which is homologous to the Drosophila armadillo gene product
(McCrea and Gumbiner, 1991) and distinct but closely related to
plakoglobin (Sutz et a/.. 1992); 'f<'atenin (80 kDa). the molecular
structure of which has not yet been characterized. Lack of binding
to catenins results in loss of the cell-cell adhesion function of E-
cadherin mutants, despite their expression at the cell surface
(Nagafuchi and Takeichi, 1989; Ozawa et al.. 1990b). rlN-catenin
is a recently identified subtype of f1-<:atenin (now termed aE..catenin)
that is expressed mainly in the nervous system where it is associated
with N-{;adherin. Recent work with Xenopus embryos indicated that
the cytoplasmic domains of different cadherins may compete for
binding to eaten ins (Kintner, 1992). During early cleavage in
Xenopus, the surface epithelium expresses P-cadherin; later, the
animal pole ectoderm produces epidermal epithelium and
neuroepithelium expressing E-cadherin and N-cadherin respectively
(Hatta and Takeichi, 1986; Choi and Gumbiner, 1989; Choi et al.,
1990; Angres et at.. 1991; Ginsberg et at., 1991; Levi et at.. 1991).
Injection of large amounts of N-cadherin RNA into the animal pole
caused loss of cell-cell adhesion suggesting that N-cadherin dis-
turbed the function of E-cadherin (Detrick et al., 1990). The same
result was obtained with a mutant form of N-cadherin coined N-
Cadc.E that contained a signal peptide, the transmembrane and the
intracellular domain but completely lacked the extracellular part of
the molecule. Inhibition of cell-ceil adhesion in Xenopus ectoderm
both in the embryo and in vitro was explained through competition
between E-cadherin and N-Cadc.E for binding to catenins. Such
competition mayregulatecell-cell adhesion in tissues that transiently
express different types of cadherin during morphogenesis. Lung
carcinoma PC9 cells, expressing E-cadherin at their surface and B-
catenin in their cytoplasm but neithera-catenin norflN-catenin, grew
as isolated cells (Hirano et at.. 1992). When these cells were
transfected with rlN-cadherin cDNA they formed aggregates show-
ing epithelial and sometimes also cystic organization. The authors
concluded that uN-catenin was crucial not only for E-cadherin-
mediated cell-cell adhesion but also for the organization of
multicellular structures. Howthe E-cadherin/catenin complex fulfils
this task is not understood.
There are observations that open new and intriguing ways of
regulating E-cadherin function but the molecular mechanisms
remain to be elucidated.
We demonstrated E-cadherin at the surface of human MCF-7/6
mammary carcinoma cells by immunocytochemistry with different
monoclona! antibodies. Nevertheless, MCF-7/6 cells failed to
aggregate in the presence of Ca2+. and they were invasive into
embryonic chick heart fragments in organ culture (our unpublished
observations). This indicates that E-cadherin was not functional in
MCF-7 cells with regard to cell-cell aggregation and invasion.
Treatment of MCF-7/6 cells with 0.5 ~lg/ml insulin-like growth factor
I (IGF-I) led to Ca2+-dependent aggregation and to inhibition of in-
vasion in vitro. The effect of IGF-I on cellular aggregation did not
necessitate de novo protein synthesis, as evidenced by cycloheximide
treatment. Monoclonal antibodies that bound to either the IGF-I
receptor or E-cadherin abrogated the effect of IGF-I on Ca2+-de-
pendent fast aggregation. These results indicate that the function
of E-cadherin can be regulated by IGF-I at least in MCF-7/6 celis by
an, as yet, unknown mechanism.
The motogenic mitogen, called scatter factor/hepatocyte growth
factor (SF/HGF), induced loss of epithelial organization of several
types of cells on solid substrate and invasion into collagen type 1
gels; it did not, however, affect the steady state level, stability or
overall phosphorylation of E-cadherin (Weidner et at., 1990). Pos-
sible explanations are: the signal cascade triggered by SF/HGF
bypasses the E-cadherin-mediated cell adhesion system, or SF/
HGF causes as yet unidentified alterations in E-cadherin or in its
associated proteins.
Conclusions
Circumstantial and experimental evidence indicates that the cell-
cell adhesion molecule E-cadherin (also called uvomorulin) coun-
teracts embryonic ingression and cancer invasion. In the micro-
ecosystem, in which invasion and ingression are governed by the
balance between the activation of promoter and suppressor genes,
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E-cadherin is the first well documented suppressor gene product
(Fig. 4). Such a balance may act in a direct way. In such cases, the
promoter gene product functionally inactivates the suppressor gene
product or vice versa. The balance may also act in a more indirect
and general way. In such cases, changes that are unrelated to the
above-mentioned promoter or suppressor genes may, neverthe-
less, interfere with the proper function of the gene products. Our
continued interest in the invasion/ingression-suppressor role of E-
cadherin is motivated by E-cadherin's domain organization permitting
regulation at multiple post-translational levels besides the tran-
scriptionallevel, and by E-cadherin's activity as a master molecule
regulating the formation of epithelial junctional complexes.
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